288 related articles for article (PubMed ID: 20218995)
1. Use of additional oxytocin to reduce blood loss at elective caesarean section: A randomised control trial.
Güngördük K; Asicioglu O; Celikkol O; Olgac Y; Ark C
Aust N Z J Obstet Gynaecol; 2010 Feb; 50(1):36-9. PubMed ID: 20218995
[TBL] [Abstract][Full Text] [Related]
2. Utilization of carbetocin for prevention of postpartum hemorrhage after cesarean section: a randomized clinical trial.
Borruto F; Treisser A; Comparetto C
Arch Gynecol Obstet; 2009 Nov; 280(5):707-12. PubMed ID: 19229549
[TBL] [Abstract][Full Text] [Related]
3. A randomised controlled trial of oxytocin 5IU and placebo infusion versus oxytocin 5IU and 30IU infusion for the control of blood loss at elective caesarean section--pilot study. ISRCTN 40302163.
Murphy DJ; MacGregor H; Munishankar B; McLeod G
Eur J Obstet Gynecol Reprod Biol; 2009 Jan; 142(1):30-3. PubMed ID: 18977579
[TBL] [Abstract][Full Text] [Related]
4. Oxytocin-ergometrine co-administration does not reduce blood loss at caesarean delivery for labour arrest.
Balki M; Dhumne S; Kasodekar S; Kingdom J; Windrim R; Carvalho JC
BJOG; 2008 Apr; 115(5):579-84. PubMed ID: 18333937
[TBL] [Abstract][Full Text] [Related]
5. Oxytocin requirements at elective cesarean delivery: a dose-finding study.
Carvalho JC; Balki M; Kingdom J; Windrim R
Obstet Gynecol; 2004 Nov; 104(5 Pt 1):1005-10. PubMed ID: 15516392
[TBL] [Abstract][Full Text] [Related]
6. Maternal hemodynamics after oxytocin bolus compared with infusion in the third stage of labor: a randomized controlled trial.
Davies GA; Tessier JL; Woodman MC; Lipson A; Hahn PM
Obstet Gynecol; 2005 Feb; 105(2):294-9. PubMed ID: 15684155
[TBL] [Abstract][Full Text] [Related]
7. Up-down determination of the ED(90) of oxytocin infusions for the prevention of postpartum uterine atony in parturients undergoing Cesarean delivery.
George RB; McKeen D; Chaplin AC; McLeod L
Can J Anaesth; 2010 Jun; 57(6):578-82. PubMed ID: 20238255
[TBL] [Abstract][Full Text] [Related]
8. Double-blind, randomized comparison of the effect of carbetocin and oxytocin on intraoperative blood loss and uterine tone of patients undergoing cesarean section.
Boucher M; Horbay GL; Griffin P; Deschamps Y; Desjardins C; Schulz M; Wassenaar W
J Perinatol; 1998; 18(3):202-7. PubMed ID: 9659650
[TBL] [Abstract][Full Text] [Related]
9. Carbetocin versus syntometrine for the third stage of labour following vaginal delivery--a double-blind randomised controlled trial.
Su LL; Rauff M; Chan YH; Mohamad Suphan N; Lau TP; Biswas A; Chong YS
BJOG; 2009 Oct; 116(11):1461-6. PubMed ID: 19538418
[TBL] [Abstract][Full Text] [Related]
10. Oxytocin bolus versus oxytocin bolus and infusion for control of blood loss at elective caesarean section: double blind, placebo controlled, randomised trial.
Sheehan SR; Montgomery AA; Carey M; McAuliffe FM; Eogan M; Gleeson R; Geary M; Murphy DJ;
BMJ; 2011 Aug; 343():d4661. PubMed ID: 21807773
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of intravenous tranexamic acid in reducing blood loss after elective cesarean section: a prospective, randomized, double-blind, placebo-controlled study.
Gungorduk K; Yıldırım G; Asıcıoğlu O; Gungorduk OC; Sudolmus S; Ark C
Am J Perinatol; 2011 Mar; 28(3):233-40. PubMed ID: 20979013
[TBL] [Abstract][Full Text] [Related]
12. Five unit bolus oxytocin at cesarean delivery in women at risk of atony: a randomized, double-blind, controlled trial.
King KJ; Douglas MJ; Unger W; Wong A; King RA
Anesth Analg; 2010 Dec; 111(6):1460-6. PubMed ID: 20889945
[TBL] [Abstract][Full Text] [Related]
13. [Benefit of misoprostol for prevention of postpartum hemorrhage in cesarean section: a randomized controlled trial].
Fekih M; Jnifene A; Fathallah K; Ben Regaya L; Memmi A; Bouguizene S; Chaieb A; Bibi M; Khairi H
J Gynecol Obstet Biol Reprod (Paris); 2009 Nov; 38(7):588-93. PubMed ID: 19833454
[TBL] [Abstract][Full Text] [Related]
14. Carbetocin versus oxytocin to reduce additional uterotonic use at non-elective caesarean section: a double-blind, randomised trial (.).
Whigham CA; Gorelik A; Loughnan TE; Trivedi A
J Matern Fetal Neonatal Med; 2016 Dec; 29(23):3866-9. PubMed ID: 26940081
[TBL] [Abstract][Full Text] [Related]
15. Minimum oxytocin dose requirement after cesarean delivery for labor arrest.
Balki M; Ronayne M; Davies S; Fallah S; Kingdom J; Windrim R; Carvalho JC
Obstet Gynecol; 2006 Jan; 107(1):45-50. PubMed ID: 16394038
[TBL] [Abstract][Full Text] [Related]
16. Study protocol. ECSSIT - Elective Caesarean Section Syntocinon Infusion Trial. A multi-centre randomised controlled trial of oxytocin (Syntocinon) 5 IU bolus and placebo infusion versus oxytocin 5 IU bolus and 40 IU infusion for the control of blood loss at elective caesarean section.
Murphy DJ; Carey M; Montgomery AA; Sheehan SR;
BMC Pregnancy Childbirth; 2009 Aug; 9():36. PubMed ID: 19703279
[TBL] [Abstract][Full Text] [Related]
17. Effect of uterotonics on intra-operative blood loss during laparoscopy-assisted vaginal hysterectomy: a randomised controlled trial.
Chang FW; Yu MH; Ku CH; Chen CH; Wu GJ; Liu JY
BJOG; 2006 Jan; 113(1):47-52. PubMed ID: 16398771
[TBL] [Abstract][Full Text] [Related]
18. Effect of sublingual misoprostol versus intravenous oxytocin on reducing blood loss at cesarean section in Nigeria: a randomized controlled trial.
Owonikoko KM; Arowojolu AO; Okunlola MA
J Obstet Gynaecol Res; 2011 Jul; 37(7):715-21. PubMed ID: 21375669
[TBL] [Abstract][Full Text] [Related]
19. Prevention of postpartum haemorrhage with the oxytocin analogue carbetocin.
Rath W
Eur J Obstet Gynecol Reprod Biol; 2009 Nov; 147(1):15-20. PubMed ID: 19616358
[TBL] [Abstract][Full Text] [Related]
20. Intravenous oxytocin dosing regimens for postpartum hemorrhage prevention following cesarean delivery: a systematic review and meta-analysis.
Phung LC; Farrington EK; Connolly M; Wilson AN; Carvalho B; Homer CSE; Vogel JP
Am J Obstet Gynecol; 2021 Sep; 225(3):250.e1-250.e38. PubMed ID: 33957113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]